Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Arteriolar hyalinization in implantation kidney biopsy as predictor of the graft function

E Ważna, J Pazik, Z Lewandowski, A Perkowska-Ptasińska, S Nazarewski, A Chmura, M Durlik

Ann Transplant 2009; 14(1): 22-22 :: ID: 880279

Abstract

Background: Many factors influence long-term function of transplanted kidney. Increasing number of evidences support the fact that histological assessment of implantation kidney biopsies can predict short- and long-term graft survival. Objective: Kidney function evaluation 2 years after transplantation depends on implantation chronic abnormalities present in donor's biopsy.
Material/Methods: Inclusion criteria: engraftment between 2006-2007 and serum creatinine concentration 1-2 mg/dl at 3 months after transplantation. By chronic abnormalities present in the donors' biopsy were understood arteriolar hyalinization (ah), interstitial fibrosis (ci), sclerotisation of the intimae (cv), tubular atrophy (ct), total inflammation (ti) and sclerotic glomeruli (Banff 2004). Graft function 2 years after engraftment was evaluated by eGFR C&G and serum creatinine concentration. Median observation time was 24.4 (15-32) months. Statistical analysis was performed using GLM Procedure of SAS System.
Results: Baseline transplant function (3 months after transplantation) was  similar in groups with and without chronic abnormalities. In the group with at least one abnormality in comparison to the group without abnormalities in biopsy (24 vs. 14) similar graft function after two years was found. However, graft function was significantly diminished in individuals with graft affected by arteriolar hyalinization (ah) compared to recipients free from ah (16 vs. 36) (mean eGFR values: 51.2±14.8 and 62.0±16.7, respectively - p <0.03, serum creatinine concentrations were 1.76±0.36 and 1.51±0.48 mg/dl, respectively - p<0.09).
Conclusions: The only predictor of graft function at 2 years was ah type abnormalities at implantation. This finding should be considered while choosing immunosuppressive regimen.

Keywords: Kidney Transplantation

Add Comment 0 Comments

In Press

Case report  

Tongue Carcinoma in Immunosuppressed Patients After Liver and Kidney Transplantation: A Case Series

Ann Transplant In Press; DOI: 10.12659/AOT.951715  

Original article  

Prevalence and Risk Factors of Hepatic Steatosis in Kidney Transplant Recipients

Ann Transplant In Press; DOI: 10.12659/AOT.952251  

Original article  

The Anatomical Landscape of Living Donor Livers: A 101-Case Retrospective Single-Center Study in Indonesia ...

Ann Transplant In Press; DOI: 10.12659/AOT.952031  

Original article  

Decreased Ventilation Duration and ICU Stay Associated With Early Percutaneous Dilatational Tracheostomy Af...

Ann Transplant In Press; DOI: 10.12659/AOT.953143  

Most Viewed Current Articles

24 Aug 2021 : Review article   20,545

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

29 Dec 2021 : Original article   16,641

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

05 Apr 2022 : Original article   15,898

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   15,796

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358